Follow The Filings

ALHC Alignment Healthcare Inc.

Health Care, filed as ALIGNMENT HEALTHCARE INC (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by ALHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALHC insider trades
  • $198K bought by 1 insider
  • $413M sold by 2 insiders outside a trading plan
  • $76.4M sold by 6 insiders under 10b5-1 plans
  1. John E Kao CEO
    Planned sale
    $356K 27,400 shares at $13.00 4.4% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  2. John E Kao CEO
    Planned sale
    $2.2M 172,600 shares at $12.96 22% of stake
    Traded Sep 10 Filed Sep 11
    ↗
  3. Dawn Christine Maroney President
    Planned sale
    $70K 5,000 shares at $14.00 0.5% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  4. John E Kao CEO
    Planned sale
    $4.1M 298,000 shares at $13.88 27% of stake
    Traded Aug 10 Filed Aug 10
    ↗
  5. Dawn Christine Maroney President
    Planned sale
    $3.7M 177,068 shares at $20.83 16% of stake
    Traded Jul 15 Filed Jul 16
    ↗
  6. John E Kao CEO
    Planned sale
    $5.9M 298,000 shares at $19.86 22% of stake
    Traded Jul 10 Filed Jul 14
    ↗
  7. Joseph S Konowiecki EVP, Corporate Affairs
    Planned sale
    $600K 25,000 shares at $24.00 2.2% of stake
    Traded Jul 1 Filed Jul 1
    ↗
  8. Joseph S Konowiecki EVP, Corporate Affairs
    Planned sale
    $575K 25,000 shares at $23.00 2.2% of stake
    Traded Jun 26 Filed Jun 26
    ↗
  9. Joseph S Konowiecki EVP, Corporate Affairs
    Planned sale
    $550K 25,000 shares at $22.00 2.1% of stake
    Traded Jun 18 Filed Jun 18
    ↗
  10. Dawn Christine Maroney President
    Planned sale
    $586K 30,000 shares at $19.55 3.1% of stake
    Traded Jun 15 Filed Jun 15
    ↗
  11. Hyong Kim Chief Medical Officer
    Planned sale
    $714K 35,951 shares at $19.86 9.8% of stake
    Traded Jun 12 Filed Jun 15
    ↗
  12. Joseph S Konowiecki EVP, Corporate Affairs
    Planned sale
    $525K 25,000 shares at $21.00 2.1% of stake
    Traded Jun 11 Filed Jun 12
    ↗
  13. John E Kao CEO
    Planned sale
    $6.1M 298,000 shares at $20.36 18% of stake
    Traded Jun 10 Filed Jun 12
    ↗
  14. Mark D. Kent President - MSO
    Buy
    $198K 14,848 shares at $13.31 New stake
    Traded Jun 2 Filed Jun 2
    ↗
  15. Dawn Christine Maroney President
    Planned sale
    $483K 30,000 shares at $16.09 2.9% of stake
    Traded May 15 Filed May 19
    ↗

Also filed in the last 12 months, not counted as buying or selling: 31 sales to cover taxes, 20 stock grants, 3 gifts, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.03,7.01 Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated about 22 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.8B — —
Net income -$148.02M -$128.04M -$0.724M
Net margin * -8.2% — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $483.54M $661.64M $951.58M
Total non-current assets * $108.34M $120.42M $114.21M
Total assets $0.592B $0.782B $1.07B
Total current liabilities $263.02M $351.84M $556.87M
Total non-current liabilities * $170.79M $329.26M $329.64M
Total equity $156.95M $99.85M $179.28M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$59.19M $34.77M $139.93M
Cash from investing -$147.26M $39.19M -$14.97M
Cash from financing $0.105M $156.03M $18.04M
Net change in cash * -$206.34M $229.99M $142.99M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.